Divine Ediebah

1.1k total citations
21 papers, 818 citations indexed

About

Divine Ediebah is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Divine Ediebah has authored 21 papers receiving a total of 818 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Divine Ediebah's work include Cancer survivorship and care (10 papers), Coronary Interventions and Diagnostics (8 papers) and Cardiac Valve Diseases and Treatments (4 papers). Divine Ediebah is often cited by papers focused on Cancer survivorship and care (10 papers), Coronary Interventions and Diagnostics (8 papers) and Cardiac Valve Diseases and Treatments (4 papers). Divine Ediebah collaborates with scholars based in Netherlands, Belgium and Canada. Divine Ediebah's co-authors include Corneel Coens, Andrew Bottomley, Efstathios Zikos, Hans‐Henning Flechtner, Chantal Quinten, Jolie Ringash, Madeleine King, Martin Klein, Bryce B. Reeve and Joachim Weis and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Divine Ediebah

20 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Divine Ediebah Netherlands 13 364 330 264 151 99 21 818
Kelly W. Merriman United States 16 315 0.9× 505 1.5× 715 2.7× 77 0.5× 67 0.7× 41 1.3k
Relin Yang United States 16 266 0.7× 246 0.7× 197 0.7× 77 0.5× 48 0.5× 20 713
Jessica R. Hoag United States 15 308 0.8× 185 0.6× 290 1.1× 52 0.3× 131 1.3× 37 734
Jocelyn Andrel United States 16 404 1.1× 194 0.6× 293 1.1× 126 0.8× 56 0.6× 27 938
David Chu United States 13 425 1.2× 438 1.3× 171 0.6× 115 0.8× 88 0.9× 26 876
Steven Habbous Canada 18 296 0.8× 284 0.9× 336 1.3× 34 0.2× 249 2.5× 67 1.1k
Amanika Kumar United States 23 305 0.8× 531 1.6× 110 0.4× 176 1.2× 89 0.9× 96 1.6k
Sean R. Smith United States 17 551 1.5× 488 1.5× 181 0.7× 19 0.1× 253 2.6× 65 1.2k
Sven D’haese Belgium 7 444 1.2× 272 0.8× 458 1.7× 18 0.1× 91 0.9× 9 1.0k
G. Albrand France 16 498 1.4× 319 1.0× 389 1.5× 59 0.4× 171 1.7× 44 1.5k

Countries citing papers authored by Divine Ediebah

Since Specialization
Citations

This map shows the geographic impact of Divine Ediebah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Divine Ediebah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Divine Ediebah more than expected).

Fields of papers citing papers by Divine Ediebah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Divine Ediebah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Divine Ediebah. The network helps show where Divine Ediebah may publish in the future.

Co-authorship network of co-authors of Divine Ediebah

This figure shows the co-authorship network connecting the top 25 collaborators of Divine Ediebah. A scholar is included among the top collaborators of Divine Ediebah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Divine Ediebah. Divine Ediebah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kozuma, Ken, Kengo Tanabe, Takayuki Okamura, et al.. (2020). Long-Term Outcomes of Absorb Bioresorbable Vascular Scaffold vs. Everolimus-Eluting Metallic Stent　― A Randomized Comparison Through 5 Years in Japan ―. Circulation Journal. 84(5). 733–741. 15 indexed citations
2.
Kereiakes, Dean J., Stephen G. Ellis, D. Christopher Metzger, et al.. (2019). Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption. Circulation. 140(23). 1895–1903. 61 indexed citations
3.
Suzuki, Nobuaki, Ken Kozuma, Sunao Nakamura, et al.. (2019). Absorb GT1 Bioresorbable Vascular Scaffold System　― 1-Year Post-Marketing Surveillance in Japan ―. Circulation Journal. 83(12). 2460–2465. 6 indexed citations
4.
Ediebah, Divine, Chantal Quinten, Corneel Coens, et al.. (2018). Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials. Cancer. 124(16). 3409–3416. 70 indexed citations
5.
Costa, J. Ribamar, Alexandre Abizaid, Robert Whitbourn, et al.. (2018). Three‐year clinical outcomes of patients treated with everolimus‐eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial. Catheterization and Cardiovascular Interventions. 93(1). E1–E7. 8 indexed citations
6.
Dudek, Dariusz, Łukasz Rzeszutko, Yoshinobu Onuma, et al.. (2017). Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation. JACC: Cardiovascular Interventions. 10(8). 786–795. 19 indexed citations
7.
Ediebah, Divine, Jaap C. Reijneveld, Martin Klein, et al.. (2016). Impact of neurocognitive deficits on patient–proxy agreement regarding health-related quality of life in low-grade glioma patients. Quality of Life Research. 26(4). 869–880. 30 indexed citations
8.
Serruys, Patrick W., John Ormiston, Robert‐Jan van Geuns, et al.. (2016). A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis. Journal of the American College of Cardiology. 67(7). 766–776. 119 indexed citations
9.
10.
Zikos, Efstathios, Corneel Coens, Chantal Quinten, et al.. (2015). The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative. JNCI Journal of the National Cancer Institute. 108(5). djv391–djv391. 27 indexed citations
11.
12.
Serruys, Patrick W., Yoshinobu Onuma, Robert J. Van Geuns, et al.. (2015). TCT-11 Five-year Follow up of the First in Man use of a Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis; A Serial Multi-Imaging Modality Study. Journal of the American College of Cardiology. 66(15). B5–B5.
13.
Zikos, Efstathios, et al.. (2014). Measuring the Quality of Life of Patients with Cancer. European Oncology & Haematology. 10(1). 10–10. 1 indexed citations
14.
Ediebah, Divine, Francisca Galindo‐Garre, Bernard M.J. Uitdehaag, et al.. (2014). Joint modeling of longitudinal health-related quality of life data and survival. Quality of Life Research. 24(4). 795–804. 18 indexed citations
15.
Ediebah, Divine, Corneel Coens, Efstathios Zikos, et al.. (2014). Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. British Journal of Cancer. 110(10). 2427–2433. 74 indexed citations
16.
Zikos, Efstathios, Irina Ghislain, Corneel Coens, et al.. (2014). Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials. The Lancet Oncology. 15(2). e78–e89. 32 indexed citations
17.
Quinten, Chantal, Francesca Martinelli, Corneel Coens, et al.. (2013). A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Cancer. 120(2). 302–311. 155 indexed citations
18.
Ediebah, Divine, Corneel Coens, John Maringwa, et al.. (2012). Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients. Annals of Oncology. 24(1). 231–237. 12 indexed citations
19.
Zikos, Efstathios, Corneel Coens, Divine Ediebah, et al.. (2012). Health-related quality of life assessment in EORTC cancer clinical trials.. Journal of Clinical Oncology. 30(15_suppl). 6090–6090. 1 indexed citations
20.
Quinten, Chantal, Efstathios Zikos, Eva Greimel, et al.. (2012). An international study of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different cancer sites.. Journal of Clinical Oncology. 30(15_suppl). 6002–6002. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kelly W. Merriman Breakdown of academic impact, for papers by Relin Yang Breakdown of academic impact, for papers by Jessica R. Hoag Breakdown of academic impact, for papers by Jocelyn Andrel Breakdown of academic impact, for papers by David Chu Breakdown of academic impact, for papers by Steven Habbous Breakdown of academic impact, for papers by Amanika Kumar Breakdown of academic impact, for papers by Sean R. Smith Breakdown of academic impact, for papers by Sven D’haese Breakdown of academic impact, for papers by G. Albrand
Rankless by CCL
2026